Skip to main content
. 2020 Jul 2;36:148. doi: 10.11604/pamj.2020.36.148.20498

Table 2.

consistency between VM1A and HF vaccine utilization MSF versus characteristics of reporting HF

HF Characteristics HF with Poor Consistency (N=965) HF with Good Consistency (N=90) Total (N=1055) P-value
Availability of trained staff at the facility No 95 (9.8%) 1 (1.1%) 96 (9.1%) 0.006
Yes 870 (90.2%) 89 (98.9%) 959 (90.9%)
Number of Health Workers trained on RI tools per facility No trained Health Worker 91 (9.4%) 1 (1.1%) 92 (8.7%) 0.023
One trained Health Worker 663 (68.7%) 70 (77.8%) 733 (69.5%)
At least 2 trained health 211 (21.9%) 19 (21.1%) 230 (21.8%)
Tools Availability at the HF level Incomplete RI data tools 203 (21.0%) 12 (13.3%) 215 (20.4%) 0.083
Complete RI data tools 762 (79.0%) 78 (86.7%) 840 (79.6%)
When was the last time someone from this HF attended LGA meeting No Response 79 (8.2%) 0 (0.0%) 79 (7.5%) 0.044
Less than 1 month 841 (87.2%) 85 (94.4%) 926 (87.8%)
2-4 months 24 (2.5%) 3 (3.3%) 27 (2.6%)
More than 4 months 21 (2.2%) 2 (2.2%) 23 (2.2%)
When was the last time this HF had a RI SS visit from the LGA No Response 91 (9.4%) 1 (1.1%) 92 (8.7%) 0.053
One Month or less 821 (85.1%) 82 (91.1%) 903 (85.6%)
2-4 Months 32 (3.3%) 4 (4.4%) 36 (3.4%)
4 Months or more 21 (2.2%) 3 (3.3%) 24 (2.3%)

HF with poor data consistency had >10% discrepancy level between vaccine management tool 1A (VM1a) and HF vaccine utilization summary form while HF with good data consistency had <10% discrepancy level between vaccine management tool (VM1a) and HF vaccine utilization summary. Discrepancy was measured based on 3 antigens bacille Calmette-Guerin, Pentavalent and Meales vaccines